Skip to main content
Equibles

Tower Research Capital LLC (TRC)

Position in IFRX — InflaRx N.V.

CIK 1533421 NEW YORK, NY
Back to IFRX Full portfolio

Position in IFRX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$6,482
-$6,555 QoQ
Shares Held
2,894
-65.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 62 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IFRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $49,739,988 across 466 Biotechnology names. IFRX ranks #343 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 4,547 $4,218,570
2 BBIO
BridgeBio Pharma, Inc.
 38,206 $2,845,582
3 ARWR
Arrowhead Pharmaceuticals, Inc.
 34,537 $2,815,110
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 4,292 $2,131,964
5 MDGL
Madrigal Pharmaceuticals, Inc.
 3,927 $2,108,602
6 AXSM
Axsome Therapeutics, Inc.
 6,437 $1,575,584
7 INSM
INSMED Inc
 10,927 $1,165,036
8 ROIV
Roivant Sciences Ltd.
 32,746 $1,158,880

All Filings in IFRX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,482 2,894
2024-03-31 $13,037 8,466
2023-12-31 $9,651 5,921
2023-09-30 $23,905 8,022
2023-06-30 $8,380 1,879
2023-03-31 $7,377 4,646
2022-12-31 $6,317 2,038
2022-09-30 $6,977 2,643
2022-06-30 $5,457 3,764
2021-12-31 $1,099 231
2020-12-31 $23,086 4,590
2020-09-30 $8,314 1,952
2020-06-30 $9,528 2,076
2020-03-31 $1,004 263